Anna Vakhrusheva
Chief Executive Officer at Unlimited Bio
Anna Vakhrusheva works as a lead bioengineer at Longaevus, where she is able to explore her interests in anti-aging therapies, immunology and drug development. After receiving a PhD in Bioengineering from MSU, Anna started working as CEO of “Betuvax”, a company that works on vaccine development from RnD to clinical trials. Furthermore, Anna has a medical degree, which allows her to bring valuable hands-on experience from both medical and research perspectives to Longaevus.
Visit website: https://unlimit.bio/#team
See also
Details last updated 27-Apr-2025
Anna Vakhrusheva is also referenced in the following:
Genii Longevity 2025
16-Jun-2025
Shaping the Future of Longevity Innovation, event organised by International Longevity Alliance (Geneva, Switzerland)
